Recommendations for Screening, Risk Stratification, and Targeted Treatment for Diabetic Kidney Disease in the UAE

Abstract Diabetes remains the leading cause of diabetic kidney disease (DKD) and end-stage renal disease (ESRD), posing a significant health care burden both globally and in the United Arab Emirates. The coexistence of DKD and cardiovascular risk factors increases morbidity and mortality, necessitating the need for an integrated, evidence-based approach in management. In response, a panel of endocrinologists and nephrologists from the United Arab Emirates collaborated to develop regional consensus recommendations focusing on the local clinical needs. This article focuses on DKD stage 1 to 4, providing practical guidance on screening, diagnosis, referral, glycemic control, and risk factor management to help delay DKD progression and reduce complications. Given the complexity of DKD, additional recommendations covering advanced stages, dialysis, and transplantation will be presented as a forthcoming part of this consensus. These recommendations support a proactive and comprehensive approach to improve renal–metabolic outcomes and address the escalating burden of DKD in the United Arab Emirates.